Scilex Holding Company Other Underwriting Expense
Scilex Holding Company (SCLX) reported Other Underwriting Expense of $2.40 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherUnderwritingExpense · last filed 2022-11-04
- Scilex Holding Company other underwriting expense for the quarter ending 2022-09-30 was $0.00.
- Scilex Holding Company other underwriting expense for the quarter ending 2022-06-30 was $0.00.
- Scilex Holding Company other underwriting expense for the quarter ending 2022-03-31 was $2.40M, a 0.00% change year-over-year.
- Scilex Holding Company other underwriting expense for the quarter ending 2021-12-31 was $0.00.
- Scilex Holding Company other underwriting expense for fiscal 2021 was $2.40M.
| Period end | Other Underwriting Expense 3 month | Other Underwriting Expense 6 month | Other Underwriting Expense 9 month | Other Underwriting Expense 10 month | Other Underwriting Expense 12 month |
|---|---|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $0.00 derived: sum of 2 quarters · filed 2022-11-04 | $2.40M 10-Q · filed 2022-11-04 | $2.40M derived: sum of 4 quarters · filed 2022-11-04 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $2.40M 10-Q · filed 2022-08-12 | $2.40M derived: sum of 3 quarters · filed 2022-08-12 | $2.40M derived: sum of 4 quarters · filed 2022-08-12 | |
| 2022-03-31 | $2.40M 10-Q · filed 2022-05-16 | $2.40M derived: sum of 2 quarters · filed 2022-05-16 | $2.40M derived: sum of 3 quarters · filed 2022-05-16 | $2.40M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $2.40M 10-K · filed 2022-02-24 | |
| 2021-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2021-12-08 | $0.00 derived: sum of 2 quarters · filed 2021-12-08 | $2.40M 10-Q/A · filed 2021-12-08 | ||
| 2021-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2021-08-24 | $2.40M 10-Q/A · filed 2021-08-24 | |||
| 2021-03-31 | $2.40M 10-Q · filed 2021-07-23 | ||||
| 2020-12-31 | $2.40M 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |